Biotonix (2010) Inc.

Biotonix (2010) Inc.

June 15, 2010 10:59 ET

Media Advisory/REMINDER: Biotonix to Launch GolfPrint™, a Personalized Postural Assessment Solution for Golf

BOUCHERVILLE, QUEBEC--(Marketwire - June 15, 2010) - Biotonix (2010) Inc. (TSX VENTURE:BTX) ("Biotonix")

Louise St-Onge, CEO, and Dr. Sylvain Guimond, D.O., Ph.D., President, cordially invite the media to attend the annual and special meeting of shareholders which will be followed by the launch of GolfPrint™. 

Brian Edwards, Chairman of the Board of Directors, will host the formal segment of the meeting. Louise St-Onge, CEO, will present the company as well as an overview of activities and the 2010-2012 outlook.

After this presentation, Dr. Sylvain Guimond, D.O., Ph.D., President, and Daniel Langevin CPGA, Head Coach of CPGA Quebec zone Golf-Études program, University of Montréal's Carabins Golf teams and Performance Golf Academy, will officially launch Biotonix's personalized postural assessment solution for golf. In addition, they will conduct a live GolfPrint™ evaluation and feature a testimonial from Mario Lemieux following the product's trial in Tremblant. The product's microsite,, will be unveiled at that moment.

DATE: Wednesday, June 16, 2010
TIME: Formal segment of the annual meeting: 10:00 am to 10:30 am EST
  Overview of activities and 2010-2012 outlook: 10:30 am to 11:00 am EST
  GolfPrint™ launch: 11:00 am to noon EST
PLACE: Sheraton Centre Montréal
  1201 René-Lévesque W., Montréal, H3B 2L7
  Ballroom centre

After the launch, there will be a brief session with the media, at approximately noon, in the Ballroom centre.


Biotonix (TSX VENTURE:BTX) offers innovative health solutions for posture correction and fitness using a web-based imaging software technology. Biotonix is currently developing novel orthotics for the back and foot, also geared specifically toward improving posture. For more information please visit


This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While Biotonix anticipates that subsequent events and developments may cause its views to change, Biotonix specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Biotonix
    Louise St-Onge
    Chief Executive Office
    514-840-0004, ext. 229
    Julie M. Thibodeau, B.Sc., MBA
    VP, Corporate communications and investor relations
    514-840-0004, ext. 223